Real-world, 12-month results demonstrated efficacy, safety and durability for faricimab as a treatment for retinal vein occlusion, according to a speaker at Retina 2026.In light of faricimab’s ...
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye ...
Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.
APOLLO BEACH, Fla., Feb. 20, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc OTCQB:RTGN (“RetinalGenix” or the “Company”), announced today that it has achieved an important milestone in ...
Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...
The field of retinal imaging has long provided a unique, non-invasive window to systemic vascular health, with microvascular ...
RetinalGenix Technologies Inc. [OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results